StockNews.com upgraded shares of Myriad Genetics (NASDAQ:MYGN – Free Report) from a hold rating to a buy rating in a report ...

On March 23, 2025, 23andMe Holding Co. (Nasdaq: ME), a prominent genetics and biotechnology firm, announced it has ...

Genetics testing company 23andMe has filed for Chapter 11 bankruptcy—and the possible impact of this move on data privacy has ...

Me is filing for bankruptcy. The genetics company announced it’s starting a court-supervised sale process to restructure its ...

Shares of 23andMe (NASDAQ:ME) more than doubled in the morning hours Thursday after a federal judge, hearing the company's ...

Scientists at deCODE genetics, a subsidiary of Amgen, reveal today in Nature Genetics associations between rare ...

Me has filed for the Chapter 11 process and their CEO has resigned to become an independent buyer despite her recent bid ...

On Sunday, human genetics and biotechnology company 23andMe Holding Co (NASDAQ:ME) voluntarily filed for Chapter 11 ...

Genetics firm 23andMe, maker of the once-popular take-home DNA testing kits, has filed for Chapter 11 bankruptcy, casting a looming shadow.

DNA genetics testing company 23andMe has filed for Chapter 11 bankruptcy. It emphasizes there will be uninterrupted service ...

On Sunday, March 23, 23andMe Holding Co. announced it started voluntarily filing for Chapter 11 Bankruptcy in the U.S.

Genetics company 23andMe has filed for bankruptcy and its CEO is stepping down, leaving many users concerned about the future ...